{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:43:16Z","timestamp":1786981396622,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470606"],"award-info":[{"award-number":["82470606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Construction Project of High-level Technology Talents in Public Health","award":["Discipline backbone-02-24"],"award-info":[{"award-number":["Discipline backbone-02-24"]}]},{"name":"Beijing Institute of Hepatology Reform and Development Project","award":["2024Y-KF-08; 2025Y-KF-Q08"],"award-info":[{"award-number":["2024Y-KF-08; 2025Y-KF-Q08"]}]},{"name":"Beijing You\u2019an Hospital Construction of Talent Pool Program","award":["YARCKC2022004"],"award-info":[{"award-number":["YARCKC2022004"]}]},{"name":"Open Research Project of Beijing Key Laboratory of Beijing Youan Hospital Affiliated to Capital Medical University","award":["BJYAHKF2023003"],"award-info":[{"award-number":["BJYAHKF2023003"]}]},{"name":"Beijing Natural Science Foundation","award":["7202070"],"award-info":[{"award-number":["7202070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11102-0","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:38:40Z","timestamp":1760002720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Naringin mitigates liver damage in a tissue-engineered liver of metabolic dysfunction-associated steatotic liver disease model by promoting autophagy via the mTOR-ULK1 pathway"],"prefix":"10.1007","volume":"52","author":[{"given":"Jihui","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"Suppl","key":"11102_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L (2025) Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol 31(Suppl):S32-s50. https:\/\/doi.org\/10.3350\/cmh.2024.0431","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"11102_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/hep.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME (2024) Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology 79(5):1212\u20131219. https:\/\/doi.org\/10.1097\/hep.0000000000000670","journal-title":"Hepatology"},{"key":"11102_CR3","doi-asserted-by":"publisher","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","volume":"13","author":"L Rong","year":"2022","unstructured":"Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, Guo J (2022) Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne) 13:1087260. https:\/\/doi.org\/10.3389\/fendo.2022.1087260","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"11102_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22(1):63. https:\/\/doi.org\/10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"11102_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ (2024) Resmetirom: First approval. Drugs 84(6):729\u2013735. https:\/\/doi.org\/10.1007\/s40265-024-02045-0","journal-title":"Drugs"},{"issue":"3","key":"11102_CR6","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei S, Wang L, Evans PC, Xu S (2024) NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today 29(3):103910. https:\/\/doi.org\/10.1016\/j.drudis.2024.103910","journal-title":"Drug Discov Today"},{"issue":"3","key":"11102_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR (2023) Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review. J Obes Metab Syndr 32(3):197\u2013213. https:\/\/doi.org\/10.7570\/jomes23052","journal-title":"J Obes Metab Syndr"},{"issue":"10","key":"11102_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y (2023) Autophagy: Regulator of cell death. Cell Death Dis 14(10):648. https:\/\/doi.org\/10.1038\/s41419-023-06154-8","journal-title":"Cell Death Dis"},{"issue":"6","key":"11102_CR9","doi-asserted-by":"publisher","first-page":"e202400866","DOI":"10.1002\/cmdc.20240086610","volume":"20","author":"J Shao","year":"2025","unstructured":"Shao J, Xie S, Hong S, Qian L (2025) Autophagy-mediated targeted protein degradation. ChemMedChem 20(6):e202400866. https:\/\/doi.org\/10.1002\/cmdc.20240086610","journal-title":"ChemMedChem"},{"issue":"2","key":"11102_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","volume":"20","author":"Q Ren","year":"2024","unstructured":"Ren Q, Sun Q, Fu J (2024) Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. Autophagy 20(2):221\u2013241. https:\/\/doi.org\/10.1080\/15548627.2023.2254191","journal-title":"Autophagy"},{"issue":"8","key":"11102_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/liv.13866","volume":"38","author":"X Chao","year":"2018","unstructured":"Chao X, Wang H, Jaeschke H, Ding WX (2018) Role and mechanisms of autophagy in acetaminophen-induced liver injury. Liver Int 38(8):1363\u20131374. https:\/\/doi.org\/10.1111\/liv.13866","journal-title":"Liver Int"},{"key":"11102_CR12","doi-asserted-by":"publisher","first-page":"155200","DOI":"10.1016\/j.metabol.2022.155200","volume":"131","author":"LS Yan","year":"2022","unstructured":"Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, Pan SY, Zhang Y (2022) Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway. Metabolism 131:155200. https:\/\/doi.org\/10.1016\/j.metabol.2022.155200","journal-title":"Metabolism"},{"key":"11102_CR13","doi-asserted-by":"publisher","first-page":"154561","DOI":"10.1016\/j.phymed.2022.154561","volume":"109","author":"B Shen","year":"2023","unstructured":"Shen B, Wang Y, Cheng J, Peng Y, Zhang Q, Li Z, Zhao L, Deng X, Feng H (2023) Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine 109:154561. https:\/\/doi.org\/10.1016\/j.phymed.2022.154561","journal-title":"Phytomedicine"},{"key":"11102_CR14","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20193431","author":"H Zhao","year":"2020","unstructured":"Zhao H, Liu M, Liu H, Suo R, Lu C (2020) Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP pathway. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20193431"},{"key":"11102_CR15","doi-asserted-by":"publisher","first-page":"109895","DOI":"10.1016\/j.biopha.2020.109895","volume":"125","author":"B Liu","year":"2020","unstructured":"Liu B, Deng X, Jiang Q, Li G, Zhang J, Zhang N, Xin S, Xu K (2020) Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS\/P38\/Nrf2 axis and PI3K\/AKT\/mTOR pathway in macrophages. Biomed Pharmacother 125:109895. https:\/\/doi.org\/10.1016\/j.biopha.2020.109895","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"11102_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s44324-024-00022-5","volume":"2","author":"S Raza","year":"2024","unstructured":"Raza S, Rajak S, Yen PM, Sinha RA (2024) Autophagy and hepatic lipid metabolism: Mechanistic insight and therapeutic potential for MASLD. NPJ Metab Health Dis 2(1):19. https:\/\/doi.org\/10.1038\/s44324-024-00022-5","journal-title":"NPJ Metab Health Dis"},{"issue":"8","key":"11102_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1691\/ph.2021.1504","volume":"76","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu S (2021) Bioactivity of naringin and related mechanisms. Pharmazie 76(8):359\u2013363. https:\/\/doi.org\/10.1691\/ph.2021.1504","journal-title":"Pharmazie"},{"issue":"4","key":"11102_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3945\/an.113.005603","volume":"5","author":"MA Alam","year":"2014","unstructured":"Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD (2014) Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr 5(4):404\u201317. https:\/\/doi.org\/10.3945\/an.113.005603","journal-title":"Adv Nutr"},{"key":"11102_CR19","doi-asserted-by":"publisher","first-page":"110646","DOI":"10.1016\/j.fct.2019.110646","volume":"132","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Khan H, Aschner M, Hasan MM, Hassan STS (2019) Therapeutic potential of naringin in neurological disorders. Food Chem Toxicol 132:110646. https:\/\/doi.org\/10.1016\/j.fct.2019.110646","journal-title":"Food Chem Toxicol"},{"key":"11102_CR20","doi-asserted-by":"publisher","first-page":"173535","DOI":"10.1016\/j.ejphar.2020.173535","volume":"887","author":"R Heidary Moghaddam","year":"2020","unstructured":"Heidary Moghaddam R, Samimi Z, Moradi SZ, Little PJ, Xu S, Farzaei MH (2020) Naringenin and naringin in cardiovascular disease prevention: A preclinical review. Eur J Pharmacol 887:173535. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173535","journal-title":"Eur J Pharmacol"},{"key":"11102_CR21","doi-asserted-by":"publisher","first-page":"106011","DOI":"10.1016\/j.fitote.2024.106011","volume":"176","author":"HS Yaseen","year":"2024","unstructured":"Yaseen HS, Zubair HM, Jamal A, Farrukh M, Mikrani R, Shaukat B, Hill JW, Rana R, Nazir A, Naveed M, Malik S (2024) Naringin: Cardioprotective properties and safety profile in diabetes treatment. Fitoterapia 176:106011. https:\/\/doi.org\/10.1016\/j.fitote.2024.106011","journal-title":"Fitoterapia"},{"key":"11102_CR22","doi-asserted-by":"publisher","first-page":"585066","DOI":"10.3389\/fmicb.2020.585066","volume":"11","author":"H Mu","year":"2020","unstructured":"Mu H, Zhou Q, Yang R, Zeng J, Li X, Zhang R, Tang W, Li H, Wang S, Shen T, Huang X, Dou L, Dong J (2020) Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice. Front Microbiol 11:585066. https:\/\/doi.org\/10.3389\/fmicb.2020.585066","journal-title":"Front Microbiol"},{"key":"11102_CR23","doi-asserted-by":"publisher","first-page":"118118","DOI":"10.1016\/j.lfs.2020.118118","volume":"257","author":"AA Syed","year":"2020","unstructured":"Syed AA, Reza MI, Shafiq M, Kumariya S, Singh P, Husain A, Hanif K, Gayen JR (2020) Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE\/NF-\u03baB mediated mitochondrial apoptosis. Life Sci 257:118118. https:\/\/doi.org\/10.1016\/j.lfs.2020.118118","journal-title":"Life Sci"},{"key":"11102_CR24","doi-asserted-by":"publisher","first-page":"100683","DOI":"10.1016\/j.crfs.2024.100683","volume":"8","author":"X Li","year":"2024","unstructured":"Li X, Yao Z, Qi X, Cui J, Zhou Y, Tan Y, Huang X, Ye H (2024) Naringin ameliorates obesity via stimulating adipose thermogenesis and browning, and modulating gut microbiota in diet-induced obese mice. Curr Res Food Sci 8:100683. https:\/\/doi.org\/10.1016\/j.crfs.2024.100683","journal-title":"Curr Res Food Sci"},{"issue":"3","key":"11102_CR25","doi-asserted-by":"publisher","first-page":"e2200812","DOI":"10.1002\/mnfr.202200812","volume":"68","author":"L Guan","year":"2024","unstructured":"Guan L, Guo L, Zhang H, Liu H, Zhou W, Zhai Y, Yan X, Men X, Peng L (2024) Naringin protects against non-alcoholic fatty liver disease by promoting autophagic flux and lipophagy. Mol Nutr Food Res 68(3):e2200812. https:\/\/doi.org\/10.1002\/mnfr.202200812","journal-title":"Mol Nutr Food Res"},{"key":"11102_CR26","doi-asserted-by":"publisher","first-page":"119487","DOI":"10.1016\/j.lfs.2021.119487","volume":"277","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang Y, Gao W, Guo Z, Wang K, Liu S, Duan Z, Chen Y (2021) Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms. Life Sci 277:119487. https:\/\/doi.org\/10.1016\/j.lfs.2021.119487","journal-title":"Life Sci"},{"key":"11102_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030541","author":"W Gao","year":"2022","unstructured":"Gao W, Xu B, Zhang Y, Liu S, Duan Z, Chen Y, Zhang X (2022) Baicalin attenuates oxidative stress in a tissue-engineered liver model of NAFLD by scavenging reactive oxygen species. Nutrients. https:\/\/doi.org\/10.3390\/nu14030541","journal-title":"Nutrients"},{"issue":"8","key":"11102_CR28","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1021\/acsbiomaterials.8b00652","volume":"4","author":"Q Wu","year":"2018","unstructured":"Wu Q, Liu J, Liu L, Chen Y, Wang J, Leng L, Yu Q, Duan Z, Wang Y (2018) Establishment of an ex vivo model of nonalcoholic fatty liver disease using a tissue-engineered liver. ACS Biomater Sci Eng 4(8):3016\u20133026. https:\/\/doi.org\/10.1021\/acsbiomaterials.8b00652","journal-title":"ACS Biomater Sci Eng"},{"key":"11102_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bse0550001","volume":"55","author":"LE Gallagher","year":"2013","unstructured":"Gallagher LE, Chan EY (2013) Early signalling events of autophagy. Essays Biochem 55:1\u201315. https:\/\/doi.org\/10.1042\/bse0550001","journal-title":"Essays Biochem"},{"issue":"2","key":"11102_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13(2):132\u201341. https:\/\/doi.org\/10.1038\/ncb2152","journal-title":"Nat Cell Biol"},{"key":"11102_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","volume":"144","author":"G Svegliati-Baroni","year":"2019","unstructured":"Svegliati-Baroni G, Pierantonelli I, Torquato P, Marinelli R, Ferreri C, Chatgilialoglu C, Bartolini D, Galli F (2019) Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Radic Biol Med 144:293\u2013309. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.05.029","journal-title":"Free Radic Biol Med"},{"key":"11102_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000786","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang L, Dong B (2024) Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology. https:\/\/doi.org\/10.1097\/hep.0000000000000786","journal-title":"Hepatology"},{"issue":"4","key":"11102_CR33","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1007\/s12013-024-01444-0","volume":"82","author":"KB Okesina","year":"2024","unstructured":"Okesina KB, Odetayo AF, Adeyemi WJ, Okesina AA, Bassey GE, Olayaki LA (2024) Naringin prevents diabetic-induced dysmetabolism in male Wistar rats by modulating GSK-3 activities and oxidative stress-dependent pathways. Cell Biochem Biophys 82(4):3559\u20133571. https:\/\/doi.org\/10.1007\/s12013-024-01444-0","journal-title":"Cell Biochem Biophys"},{"key":"11102_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194120","author":"C Termkwancharoen","year":"2022","unstructured":"Termkwancharoen C, Malakul W, Phetrungnapha A, Tunsophon S (2022) Naringin ameliorates skeletal muscle atrophy and improves insulin resistance in high-fat-diet-induced insulin resistance in obese rats. Nutrients. https:\/\/doi.org\/10.3390\/nu14194120","journal-title":"Nutrients"},{"issue":"1","key":"11102_CR35","doi-asserted-by":"publisher","first-page":"2386194","DOI":"10.1080\/27694127.2024.238619436","volume":"3","author":"K Furukawa","year":"2024","unstructured":"Furukawa K, Ginevskaia T, Kanki T (2024) Re-exploration of all ATG genes. Autophagy Rep 3(1):2386194. https:\/\/doi.org\/10.1080\/27694127.2024.238619436","journal-title":"Autophagy Rep"},{"issue":"1","key":"11102_CR36","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/s41467-023-38165-6","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, Acin-Perez R, Assali EA, Martin A, Brownstein AJ, Petcherski A, Fern\u00e1ndez-Del-Rio L, Xiao R, Lo CH, Shum M, Liesa M, Han X, Shirihai OS, Grinstaff MW (2023) Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nat Commun 14(1):2573. https:\/\/doi.org\/10.1038\/s41467-023-38165-6","journal-title":"Nat Commun"},{"key":"11102_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020818","author":"N Nasiri-Ansari","year":"2021","unstructured":"Nasiri-Ansari N, Nikolopoulou C, Papoutsi K, Kyrou I, Mantzoros CS, Kyriakopoulos G, Chatzigeorgiou A, Kalotychou V, Randeva MS, Chatha K, Kontzoglou K, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E (2021) Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE((-\/-)) mice by activating autophagy and reducing ER stress and apoptosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020818","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11102_CR38","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","volume":"17","author":"HS Park","year":"2021","unstructured":"Park HS, Song JW, Park JH, Lim BK, Moon OS, Son HY, Lee JH, Gao B, Won YS, Kwon HJ (2021) TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Autophagy 17(9):2549\u20132564. https:\/\/doi.org\/10.1080\/15548627.2020.1834711","journal-title":"Autophagy"},{"key":"11102_CR39","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.mam.2021.100973","volume":"82","author":"H Qian","year":"2021","unstructured":"Qian H, Chao X, Williams J, Fulte S, Li T, Yang L, Ding WX (2021) Autophagy in liver diseases: a review. Mol Aspects Med 82:100973. https:\/\/doi.org\/10.1016\/j.mam.2021.100973","journal-title":"Mol Aspects Med"},{"issue":"3","key":"11102_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1142\/s0192415x20500342","volume":"48","author":"S Raha","year":"2020","unstructured":"Raha S, Kim SM, Lee HJ, Yumnam S, Saralamma VV, Ha SE, Lee WS, Kim GS (2020) Naringin induces lysosomal permeabilization and autophagy cell death in AGS gastric cancer cells. Am J Chin Med 48(3):679\u2013702. https:\/\/doi.org\/10.1142\/s0192415x20500342","journal-title":"Am J Chin Med"},{"key":"11102_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040907","author":"P Guo","year":"2023","unstructured":"Guo P, Wang P, Liu L, Wang P, Lin G, Qu Z, Yu Z, Liu N (2023) Naringin alleviates glucose-induced aging by reducing fat accumulation and promoting autophagy in Caenorhabditis elegans. Nutrients. https:\/\/doi.org\/10.3390\/nu15040907","journal-title":"Nutrients"},{"issue":"6","key":"11102_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00210-023-02390-z","volume":"396","author":"Y Wei","year":"2023","unstructured":"Wei Y, Sun L, Liu C, Li L (2023) Naringin regulates endoplasmic reticulum stress and mitophagy through the ATF3\/PINK1 signaling axis to alleviate pulmonary fibrosis. Naunyn Schmiedebergs Arch Pharmacol 396(6):1155\u20131169. https:\/\/doi.org\/10.1007\/s00210-023-02390-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"11102_CR43","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1007\/s11033-023-08558-3","volume":"50","author":"J Zhu","year":"2023","unstructured":"Zhu J, Lin S, Zou X, Chen X, Liu Y, Yang X, Gao J, Zhu H (2023) Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin. Mol Biol Rep 50(8):6457\u20136468. https:\/\/doi.org\/10.1007\/s11033-023-08558-3","journal-title":"Mol Biol Rep"},{"issue":"2","key":"11102_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/jmau.Jmau_33_20","volume":"9","author":"YM Alharbi","year":"2021","unstructured":"Alharbi YM, Bima AI, Elsamanoudy AZ (2021) An overview of the perspective of cellular autophagy: Mechanism, regulation, and the role of autophagy dysregulation in the pathogenesis of diseases. J Microsc Ultrastruct 9(2):47\u201354. https:\/\/doi.org\/10.4103\/jmau.Jmau_33_20","journal-title":"J Microsc Ultrastruct"},{"issue":"15","key":"11102_CR45","doi-asserted-by":"publisher","first-page":"168472","DOI":"10.1016\/j.jmb.2024.168472","volume":"436","author":"G Pareek","year":"2024","unstructured":"Pareek G, Kundu M (2024) Physiological functions of ULK1\/2. J Mol Biol 436(15):168472. https:\/\/doi.org\/10.1016\/j.jmb.2024.168472","journal-title":"J Mol Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11102-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:04:55Z","timestamp":1766898295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11102"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11102-0","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20193431","asserted-by":"subject"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental study protocol was approved by the Experimental Animal Ethics Committee of Capital Medical University (Number: AEEI-2020-076), and all operations complied with the guidelines for the management and use of laboratory animals. Human Ethics: not applicable. Clinical trial number: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication in\n                      Molecular Biology Reports.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1000"}}